JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma
JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma
Recruiting · NCT07690787 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS207 a Bispecific Antibody Against PD1-VEGF in Nasopharyngeal Carcinoma | Recurrent/ Metastatic NPC | Recruiting | Phase 2 | 2026-07-13 | NCT07690787 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chinese University of Hong Kong | 480 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Clinical Oncology, Prince of Wales Hospital | Hong Kong | Hong Kong | 16 |